Abbott Laboratories (ABT)
-NYSE 36.21 
1.30(3.47%) 03:59 SGT|After Hours
:
36.21 0.00 (0.00%) 04:32 SGT
| Prev Close: | 37.51 |
|---|
| Open: | 37.21 |
|---|
| Bid: | 36.31 x 100 |
|---|
| Ask: | 36.40 x 100 |
|---|
| 1y Target Est: | 40.72 |
|---|
| Beta: | 0.47 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 36.21 - N/A |
|---|
| 52wk Range: | 29.50 - 38.77 |
|---|
| Volume: | 6,744,122 |
|---|
| Avg Vol (3m): | 6,983,730 |
|---|
| Market Cap: | 56.45B |
|---|
| P/E (ttm): | 11.04 |
|---|
| EPS (ttm): | 3.28 |
|---|
| Div & Yield: | 0.56 (1.50%) |
|---|
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- The Best Healthcare Betat Motley Fool(Wed, 19 Jun)
- Supreme Court Permits Antitrust Scrutiny Of Pharma Settlementsat Forbes(Tue, 18 Jun)
- Abbott Loves Abbott Laboratories Stockat Motley Fool(Tue, 18 Jun)
- Successor To Humira? AbbVie And Galapagos Work On Itat Seeking Alpha(Tue, 18 Jun)
- Can Cempra Beat The Superbugs?at Seeking Alpha(Tue, 18 Jun)
- Supreme Court decision on generics hits Actavis, but few other drug firmsat MarketWatch(Tue, 18 Jun)
- As top court invalidates some gene patents, biotech has moved onReuters(Fri, 14 Jun)
- Sector Snap: Analysts expect pharma restructuringAP(Tue, 28 May)
- Analysis - Ahead of reform, medical care slowdown hits U.S. companiesReuters(Mon, 22 Apr)
- Big Pharma down, not out, after Novartis patent blowReuters(Tue, 2 Apr)
- FDA Clears Testosterone GelZacks(Thu, 7 Feb)
- Zacks #5 Rank Additions for MondayZacks(Mon, 4 Feb)
- Zacks Industry Outlook Highlights: Johnson & Johnson, Hologic, Abbott Laboratories, AbbVie and Quest DiagnosticsZacks(Wed, 30 Jan)
- Covidien's 1Q Beats, Raises ViewZacks(Sat, 26 Jan)
- Zacks #5 Rank Additions for TuesdayZacks(Tue, 15 Jan)
Key Statistics
| Forward P/E (1 yr): | 16.09 |
|---|
| P/S (ttm): | 1.46 |
|---|
| Ex-Dividend Date: | 11-Apr-13 |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 2.01 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.44 |
|---|
| Mean Recommendation*: | 2.5 |
|---|
| PEG Ratio (5 yr expected): | 1.55 |
|---|
Business Summary
Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products worldwide. Its Established Pharmaceutical Products segment offers branded generic pharmaceuticals for the treatment of pancreatic exocrine ins...
View More